#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13018	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2153	601.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1735	1735	T	733	T,C	679,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13018	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2153	601.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1469	1469	C	789	C	745	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	665.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1644	1644	A	828	A,G	785,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	665.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2278	2278	C	758	C,T	704,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	665.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2352	2352	A	712	A	672	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3548	665.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2904	2904	C	726	C	692	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1956	folP	855	855	100.0	folP.l15.c4.ctg.1	1527	127.6	1	SNP	p	R229S	1	.	.	685	687	AGC	980	982	AGC	208;208;209	A;G;C	194;195;195	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5022	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3480	143.9	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	195;197;198	T;T;C	179;179;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5022	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3480	143.9	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	195;196;196	G;G;C	175;179;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5022	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3480	143.9	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	195;196;196	G;G;C	175;179;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1586	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1343	117.6	1	SNP	p	G45D	0	.	.	133	135	GGC	409	411	GGC	191;191;193	G;G,A;C	176;174,1;176	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	834	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	878	94.2	0	.	n	.	0	A197.	DEL	197	197	A	539	539	A	178	A	167	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4426	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3021	146.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1527	1529	GTC	163;163;161	G;T;C	156;155;153	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4426	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3021	146.0	1	SNP	p	D86N	0	.	.	256	258	GAC	633	635	GAC	206;206;204	G;A;C	190;186;187	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4426	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3021	146.0	1	SNP	p	R87I	0	.	.	259	261	CGT	636	638	CGT	203;200;197	C;G;T	187;185;180	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4426	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3021	146.0	1	SNP	p	S87R	1	.	.	259	261	CGT	636	638	CGT	203;200;197	C;G;T	187;185;180	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4426	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3021	146.0	1	SNP	p	R87W	0	.	.	259	261	CGT	636	638	CGT	203;200;197	C;G;T	187;185;180	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4426	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3021	146.0	1	SNP	p	S88P	0	.	.	262	264	TCC	639	641	TCC	198;200;200	T;C;C	180;184;184	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4022	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2701	148.5	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1350	1352	TGC	190;189;189	T;G;C	175;175;178	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4022	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2701	148.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1560	1562	GGC	215;215;213	G;G;C	200;197;197	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1289	1291	GCA	192;190;190	G;C;A,G	177;176;178,1	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1292	1294	ATC	188;190;191	A;T;C	176;176;176	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1304	1306	GTG	180;178;182	G;T;G	170;167;169	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1304	1306	GTG	180;178;182	G;T;G	170;167;169	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1808	1810	ACC	167;168;167	A;C;C	154;157;156	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1862	1864	GCG	180;180;182	G;C;G	152;142;151	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1862	1864	GCG	180;180;182	G;C;G	152;142;151	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1985	1987	GGC	180;180;182	G;G;C	164;165;166	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1994	1996	GGC	180;177;178	G,C;G;C	161,1;155;157	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3584	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2413	147.9	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2012	2014	TCG	162;165;166	T,G;C;G	111,8;124;133	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4976	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3121	158.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1581	1583	CCG	169;169;169	C;C;G	148;154;150	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2140	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1758	121.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	487	487	C	134	C	124	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	405	37.4	0	.	p	.	0	M18T	NONSYN	52	54	ATG	280	282	ACG	81;78;75	A;C;G	69;66;63	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	405	37.4	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	322	324	CAA	39;35;33	C;A;A	37;33;31	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	405	37.4	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	328	330	TAC	24;20;20	T;A;C	23;20;20	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	417	419	GAA	218;216;217	G;A,T;A	203;202,1;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	705	707	GAT	171;172;175	G;A;T	162;162;166	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	828	830	TCA	202;201;199	T;C;A	192;190;188	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	957	959	GTC	178;178;178	G;T;C	168;169;171	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1287	1289	GCA	172;176;177	G;C;A,G	158;162;163,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	1	SNP	p	G120K	1	.	.	358	360	AAG	663	665	AAG	178;180;179	A;A;G	168;170;166	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	1	SNP	p	A121D	1	.	.	361	363	GAC	666	668	GAC	179;179;179	G;A;C	166;164;164	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2376	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1584	149.2	1	SNP	p	D121N	0	.	.	361	363	GAC	666	668	GAC	179;179;179	G;A;C	166;164;164	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	270	porB3	990	116	92.24	porB3.l15.c30.ctg.1	277	39.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	152	154	ACG	64;61;58	A;C;G	54;51;48	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	270	porB3	990	116	92.24	porB3.l15.c30.ctg.1	277	39.3	0	.	p	.	0	T29A	NONSYN	85	87	ACC	185	187	GCC	46;44;43	G;C;C	40;40;39	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	270	porB3	990	116	92.24	porB3.l15.c30.ctg.1	277	39.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	194	196	CAA	37;33;31	C;A;A	35;31;29	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	270	porB3	990	116	92.24	porB3.l15.c30.ctg.1	277	39.3	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	200	202	TAC	22;18;18	T;A;C	21;18;18	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9222	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4818	190.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1981	1983	AAT	215;214;213	A,C;A;T	209,1;209;208	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1056	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1004	104.4	1	SNP	p	V57M	1	.	.	169	171	ATG	499	501	ATG	219;220;221	A;T;G	207;209;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
